These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 691000)

  • 1. Synthesis and antihypertensive activity of some ester progenitors of methyldopa.
    Saari WS; Freedman MB; Hartman RD; King SW; Raab AW; Randall WC; Engelhardt EL; Hirschmann R; Rosegay A; Ludden CT; Scriabine A
    J Med Chem; 1978 Aug; 21(8):746-53. PubMed ID: 691000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of succinimidoethyl and pivaloyloxyethyl esters as progenitors of methyldopa in man, rhesus monkey, dog, and rat.
    Vickers S; Duncan CA; White SD; Breault GO; Royds RB; de Schepper PJ; Tempero KF
    Drug Metab Dispos; 1978; 6(6):640-6. PubMed ID: 33026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of (R) and (S) alpha methyldopa from a chiral hydantoin containing the alpha phenylethyl group.
    León-Romo JL; Virues CI; Aviña J; Regla I; Juaristi E
    Chirality; 2002; 14(2-3):144-50. PubMed ID: 11835557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiol compounds. III Synthesis and antihypertensive activity of mercaptoacylamino acids.
    Oya M; Kato E; Matsumoto J; Kawashima Y; Iwao J
    Chem Pharm Bull (Tokyo); 1981 May; 29(5):1203-13. PubMed ID: 6794916
    [No Abstract]   [Full Text] [Related]  

  • 5. Rigid amino acids related to alpha-methyldopa.
    Cannon JG; O'Donnell JP; Rosazza JP; Hoppin CR
    J Med Chem; 1974 May; 17(5):565-8. PubMed ID: 4830265
    [No Abstract]   [Full Text] [Related]  

  • 6. Sensitive high-performance liquid chromatographic assay using electrochemical detection for a novel prodrug ester of methyldopa, pivaloyloxyethyl 3-(3,4-dihydroxyphenyl)-2-methylalaninate, in plasma and urine.
    Musson DG; Vincek WC; Dobrinska MR; Vickers S; Leidy HL
    J Chromatogr; 1984 Jun; 308():251-9. PubMed ID: 6746818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indapamide in ambulant treatment of hypertension: a comparative study with alpha-methyldopa.
    Meine H
    Postgrad Med J; 1981; 57 Suppl 2():37-8. PubMed ID: 7322958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-Hydroxy-alpha-methyltyrosine progenitors: synthesis and evaluation of some (2-oxo-1,3-dioxol-4-yl)methyl esters.
    Saari WS; Halczenko W; Cochran DW; Dobrinska MR; Vincek WC; Titus DC; Gaul SL; Sweet CS
    J Med Chem; 1984 Jun; 27(6):713-7. PubMed ID: 6737413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combined use of L-alpha-methyldopa hydrazine and methyldopa in the treatment of hypertension.
    Louis WJ; Vajda FJ; McNeil JJ; Doyle AE; Jarrott B
    Clin Exp Pharmacol Physiol Suppl; 1978; 4():17-22. PubMed ID: 354826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
    Malini PL; Strocchi E; Ambrosioni E; Magnani B
    Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action of methyldopa in the rat. Role of 3-O-methylated metabolites.
    Zavisca FG; Breau AP; Wurtman RJ
    Circ Res; 1979 Nov; 45(5):684-90. PubMed ID: 487531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of Hypertension In Pregnancy Study randomised controlled trial-are the results dependent on the choice of labetalol or methyldopa?
    Magee LA; ; von Dadelszen P; Singer J; Lee T; Rey E; Ross S; Asztalos E; Murphy KE; Menzies J; Sanchez J; Gafni A; Gruslin A; Helewa M; Hutton E; Koren G; Lee SK; Logan AG; Ganzevoort JW; Welch R; Thornton JG; Moutquin JM
    BJOG; 2016 Jun; 123(7):1135-41. PubMed ID: 26259808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dose-effect comparison of antihypertensive combinations with and without alpha-methyldopa].
    Krämer KD; Ghabussi P; Lehmann HU; Hochrein H
    MMW Munch Med Wochenschr; 1975 Apr; 117(14):579-82. PubMed ID: 806789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A controlled blind study of 4 antihypertensive agents (methyldopa and 3 sympatholytic agents)].
    Vejlsgaard V; Christensen M; Clausen E
    Ugeskr Laeger; 1967 May; 129(19):635-8. PubMed ID: 4877293
    [No Abstract]   [Full Text] [Related]  

  • 15. Trends in using beta-blockers and methyldopa for hypertensive disorders during pregnancy in a Canadian population.
    Xie RH; Guo Y; Krewski D; Mattison D; Nerenberg K; Walker MC; Wen SW
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):281-5. PubMed ID: 24139131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of methyldopa in man after oral administration of the pivaloyloxyethyl ester.
    Vickers S; Duncan CA; Ramjit HG; Dobrinska MR; Dollery CT; Gomez HJ; Leidy HL; Vincek WC
    Drug Metab Dispos; 1984; 12(2):242-6. PubMed ID: 6144491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of alpha-methyldopa (aldomet) and ST155 (catapres) in the treatment of hypertension.
    Seedat YK; Vawda EI; Mitha S; Ramasar R
    S Afr Med J; 1970 Mar; 44(10):300-1. PubMed ID: 5443298
    [No Abstract]   [Full Text] [Related]  

  • 18. [Alpha-methyldopa and renal function in arterial hypertension].
    Pessina AC; Hlede M; Pigato R; Palatini P; Dal Palù C
    Clin Ter; 1980 May; 93(3):287-94. PubMed ID: 7449342
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy of hypertension with Leron (cyclacenin) and Tadip (cyclacenin and alpha-methyldopa)].
    Stampfer E
    Wien Med Wochenschr; 1968 Jun; 118(24):551-4. PubMed ID: 5711781
    [No Abstract]   [Full Text] [Related]  

  • 20. Long term comparative study of guanfacine and alpha-methyldopa in essential hypertension.
    Rengo F; Ricciardelli B; Volpe M; Trimarco B; Saccà L; Condorelli M
    Arch Int Pharmacodyn Ther; 1980 Apr; 244(2):281-91. PubMed ID: 6996627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.